The pharmacologist spoke about the positive effect of using AI in medicine

The use of artificial intelligence (AI) in medicine and pharmacology reduces medical errors and allows you to speed up the routine part of the work of specialists. Candidate of Medical Sciences, clinical pharmacologist Andrey Kondrakhin told Izvestia about this on May 24.

He specified that AI is involved in radiology, pharmacology, histology, oncological research and other branches of medicine. In addition, the use of technology makes it easier to write prescriptions, fill out medical records, and make medical referrals.

"Time for routine diagnostic methods is being reduced, and many diagnostic methods are being digitized. <...> Accordingly, there are fewer medical errors, and it is easier for the doctor because there is no routine," summed up Kondrakhin.

He noted that digital technologies are actively used throughout the Russian healthcare system, both in the capital and in the regions.

"With the help of AI, new drugs and new proteins are being developed. It takes decades for humanity to create them, and AI allows this path to be completed in a few minutes," the pharmacologist concluded.

Neural network of clinics: AI will monitor heart complications after chemotherapy

How new technology will help simplify the lives of cancer patients

Earlier, on April 29, Dmitry Chebanov, Doctor of Sciences, systems biologist and researcher at the Memorial Sloan Kettering Cancer Center (MSKCC), told Izvestia that scientists had adapted artificial intelligence to treat rare cancers. According to him, the technology opens up new opportunities for drug development and could change the practice of personalized medicine in the coming years.

Prior to that, on February 14, Andrey Varivoda, Chairman of the Board of Directors of the DEACON Group of Companies, told Izvestia that mass implementation of AI systems in regional medical institutions is expected by 2026. He also clarified that more than 30 AI-based services for analyzing medical images are known in Russia. The systems help doctors to detect oncological diseases, pathologies of the lungs and the cardiovascular system at an early stage.